Study Summary
A single-center, single-arm, dose-escalation exploratory clinical trial on the safety, efficacy, and pharmacokinetics of R-Star001 cell injection in patients with Nectin-4-positive advanced solid tumors.
Want to learn more about this trial?
Request More InfoInterventions
R-Star001DRUG
Drug: Nectin-4-targeted CAR T-cell injection with inducing IL-18 secretion (R-Star001).
The trial consists of a traditional '3 + 3' pattern dose-escalation phase and a dose-expansion phase.
Study Locations
| Facility | City | State | Country |
|---|---|---|---|
| Cancer Hospital Chinese Academy Of Medical Sciences,Shenzhen Center | Shenzhen | Guangdong | China |